SCHEMBL23795446

SCHEMBL23795446

CCCCC/C=C(/C=C\C(=O)O)CC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.50
HCAR2 Q8TDS4 3/20 0.46
PTPN1 P18031 5/20 0.44
TERT O14746 3/20 0.40
PPARG P37231 3/20 0.40
PPARD Q03181 3/20 0.40
PPARA Q07869 3/20 0.40
MAPT P10636 2/20 0.40
BLM P54132 2/20 0.40
HSD17B10 Q99714 2/20 0.40
FABP4 P15090 2/20 0.40
GMNN O75496 1/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALOX15 P16050 1/20 0.40
APEX1 P27695 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3661608 1.00 EP300 (0.50) EP300HCAR2PTPN1TERTPPARG
SCHEMBL30695273 0.86 HCAR2 (0.41) EP300HCAR2PTPN1PPARA
SCHEMBL30695271 0.86 HCAR2 (0.41) EP300HCAR2PTPN1PPARA
SCHEMBL13347104 0.86 HCAR2 (0.41) EP300HCAR2PTPN1PPARA
SCHEMBL28342854 0.81 EP300 (0.43) EP300HCAR2PTPN1TERTPPARG
Maleic Acid SCHEMBL29124227 0.80 EP300 (0.53) EP300HCAR2PTPN1TERTPPARG
SCHEMBL28340332 0.79 EP300 (0.41) EP300HCAR2PTPN1TERTPPARG
SCHEMBL28342897 0.79 CNR1 (0.47) EP300MAPTKMT2A
SCHEMBL28342912 0.79 ALDH1A1 (0.46) EP300HCAR2PTPN1TERTPPARG
Maleic Acid SCHEMBL11695225 0.78 HCAR2 (0.64) HCAR2PPARGPPARDPPARACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210298299-A1 HARMFUL ORGANISM CONTROL COMPOSITION AND METHOD FOR USING THE SAME NIHON NOHYAKU CO., LTD. (JP) 2021-09-30 US disclosed
EP-3878282-A1 PEST CONTROL AGENT COMPOSITION AND METHOD FOR USING SAME Nihon Nohyaku Co., Ltd. (JP) 2021-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210298299-A1 HARMFUL ORGANISM CONTROL COMPOSITION AND METHOD FOR USING THE SAME C1S, ATL3, C5 EP300 3183/4885HCAR2 2507/4885PTPN1 1826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.